Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Operating Activities
Net Income $-96.9K $-231.0K $-150.9K $-69.3K $1.8M $2.9M $2.2M $1.1M
Depreciation & Amortization — — — — — — — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-56.2K $-193.0K $-156.1K $-124.9K $-190.0K $-182.1K $-35.9K $-46.6K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — $0 $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $28.6K $229.1K — — — — $0 $0
Net Change in Cash $-27.7K $36.1K $-280 $-124.9K $-190.0K $-182.1K $-35.9K $-46.6K
Free Cash Flow — — — — — — — —
← Newer Page 2 of 3 Older →